Rep. Greg Murphy (R-North Carolina) introduced the Every Dollar Counts Act on Tuesday. It would ensure out-of-pocket costs for covered prescription drugs are applied toward patients’ deductibles and ...

Marissa Plescia is a reporter for MedCity News covering payers, employers and health tech. She previously worked at Becker’s Hospital Review as a finance reporter. Before that, she was a data ...

The Department of Justice has sued both OhioHealth and NewYork-Presbyterian Hospital this year, alleging that they use ...

President Donald Trump’s 2027 budget proposes deep healthcare cuts, raising concerns about harm to patients and research.

In June of 2025, health plans made a series of commitments to improve prior authorization. On Tuesday, insurer advocacy organization AHIP and Blue Cross Blue Shield Association gave their first update ...

Another AI startup helping providers automate administrative processes picked up a significant round of capital on Thursday. Luminai CEO Kesava Kirupa Dinakaran said the startup’s platform is built ...

In today’s fast-moving, hyper-connected world, legal and compliance teams shield organizations from a constant stream of internal and external threats to sensitive data. Effectively countering these ...

Hospitals’ financial positioning is somewhat stable but still under significant pressure, mainly from rising costs and reimbursement issues, according to data released last week by Kaufman Hall. The ...

Jefferson Health in Philadelphia is suing Aetna over a new Medicare Advantage payment policy that hospitals say unfairly ...

Amazon’s health benefits program continues to expand. Amazon customers eligible for Teladoc Health’s services in diabetes, hypertension, pre-diabetes and weight management can now enroll directly ...

With tech advancing seemingly at the speed of light, healthcare delivery facilities are constantly upgrading their technologies to enhance the quality of patient care and the delivery of critical ...

Insmed’s new drug, Brinsupri, is still projected to reach blockbuster status, but an inflammatory skin disorder is no longer in the picture following a mid-stage clinical trial failure in this ...